Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Increased EGFR gene variations may predict chemotherapy outcomes in small cell lung cancer patients.

Cancer prevention has progressed with successful drugs and vaccines, but challenges remain in understanding genetic changes and improving strategies.

Baricitinib works better for alopecia areata in patients not previously treated with tofacitinib.

The androgen receptor gene doesn't help identify women likely to have female pattern hair loss.

Lysophospholipids can act as anti-inflammatory agents through specific receptors, but more research is needed.

Significant progress was made in understanding PXE, but effective treatments are still needed.

Non-coding RNAs could help detect and treat radiation damage.

Certain metabolites may help diagnose and predict polycystic ovary syndrome.

Loss of the Y chromosome in men is linked to health issues like heart disease and cancer.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Personalized skincare can be improved by understanding genetic differences and using compounds like Resveratrol and Quercetin.

KLB and EIF3C genes are key for early diagnosis of vitiligo and alopecia areata.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Screening for reproductive health issues like endometriosis, PCOS, and STDs is crucial for early detection and prevention.

American and Chinese ginseng have distinct metabolic profiles that help identify their origin.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Standardized procedures are crucial for collecting and preparing biological samples to ensure accurate clinical metabolomics results.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

Personalized medicine is important for treating skin disorders, with new treatments and connections to hormones and genetics being explored.

A new wearable system improves wound healing by monitoring infections and delivering precise treatment.

Certain RNAs may help diagnose alopecia areata by affecting keratin genes.

iPSCs could help develop treatments for hair loss.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Colorectal cancer development involves both genetic changes and epigenetic alterations like DNA methylation and microRNA changes.

Tph cells are linked to the severity of systemic lupus erythematosus.

BTNL proteins help control inflammatory bowel disease by maintaining specific immune cells.

New hair growth corticosterone levels are higher in diabetic mice, indicating long-term stress.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.